21 May 2013
Keywords: novartis, extends, terms, idera, accord, firm, pharmaceuticals
Article | 12 March 2007
US firm Idera Pharmaceuticals says that Swiss drug major Novartis has decided to extend the term of the research phase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 March 2007
20 May 2013
© 2013 thepharmaletter.com